MAPT antibody (Middle Region)
Quick Overview for MAPT antibody (Middle Region) (ABIN634593)
Target
See all MAPT AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Specificity
- MAPT antibody was raised against the middle region of MAPT
-
Purification
- Affinity purified
-
Immunogen
- MAPT antibody was raised using the middle region of MAPT corresponding to a region with amino acids NAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLAD
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
MAPT Blocking Peptide, (ABIN5614670), is also available for use as a blocking control in assays to test for specificity of this MAPT antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of MAPT antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- MAPT (Microtubule-Associated Protein tau (MAPT))
-
Alternative Name
- MAPT
-
Background
- MAPT is differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. The mutations in the gene have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy.
-
Molecular Weight
- 40 kDa (MW of target protein)
-
Pathways
- MAPK Signaling, Microtubule Dynamics, M Phase, Regulation of Cell Size
Target
-